OTC Gene Variant rs68170503: Understanding the Risks
The rs68170503 variant is a rare genetic change located within the OTC gene, which provides instructions for an enzyme critical to the urea cycle. This variant is associated with ornithine transcarbamylase deficiency, a condition that can lead to the accumulation of ammonia in the blood.
What each genotype means
Typical enzyme activity
You carry two copies of the common reference allele for this position on the OTC gene. Individuals with this genotype produce normal levels of ornithine transcarbamylase and are not genetically predisposed by this variant to hyperammonemia. Standard dietary and metabolic recommendations apply.
Carried by more than 99.9% of individuals across all major ancestry populations worldwide.
Heterozygous carrier status
You carry one copy of the rare variant allele associated with partial ornithine transcarbamylase deficiency. In females, this heterozygous carrier state can lead to variable clinical effects depending on X-chromosome inactivation, ranging from asymptomatic to an increased risk of elevated blood ammonia during metabolic stress such as illness, fasting, or high-protein intake. This finding does not represent a definitive diagnosis, and discussing individual risk factors or management strategies with a physician or genetic counselor is advised.
Extremely rare, observed in fewer than 1 in 10,000 individuals across global populations in gnomAD.
Elevated hyperammonemia risk
You carry two copies of the variant allele in the X-linked OTC gene, reflecting an altered ornithine transcarbamylase sequence. This profile is statistically associated with impaired ammonia clearance through the urea cycle and an increased vulnerability to acute hyperammonemic episodes when under physiological stress, infections, or excessive protein intake. Clinical assessment and discussion with a medical genetics specialist or metabolic physician are recommended to evaluate personal management options.
Extremely rare worldwide, with an estimated prevalence well below 1 in 100,000 individuals.
What is rs68170503?
The rs68170503 variant is a single nucleotide polymorphism (SNP) situated on the X chromosome within the OTC gene. In genetic databases, this variant is identified by its specific location and the potential for different nucleotide bases to occupy that position. Because the OTC gene is located on the X chromosome, the inheritance pattern and clinical expression of variants in this gene are influenced by an individual's sex. Males have only one X chromosome, meaning a single copy of a pathogenic variant is sufficient to affect enzyme function, while females have two X chromosomes and may experience variable symptoms due to a process called X-inactivation, where one X chromosome is silenced in each cell. Understanding this variant requires looking at how it alters the genetic code and whether that change disrupts the production or function of the ornithine transcarbamylase enzyme.
The Role of the OTC Gene
The OTC gene encodes the enzyme ornithine transcarbamylase, which plays a vital role in the urea cycle. The urea cycle is a series of biochemical reactions that take place primarily in the liver to convert toxic ammonia—a byproduct of protein metabolism—into urea, which is then safely excreted by the kidneys. When the OTC enzyme is missing or not functioning correctly, ammonia cannot be processed efficiently and begins to build up in the bloodstream, a condition known as hyperammonemia. High levels of ammonia are toxic, particularly to the central nervous system, and can lead to serious health complications. Because the urea cycle is essential for maintaining nitrogen balance in the body, variants that significantly impair OTC activity are considered clinically significant and are the primary cause of ornithine transcarbamylase deficiency.
Research and Clinical Evidence
Research into rs68170503 has linked it to ornithine transcarbamylase deficiency, a condition characterized by a wide spectrum of clinical severity. Scientific literature indicates that while some variants in the OTC gene lead to severe, neonatal-onset hyperammonemia, others may result in a milder, late-onset form of the disease that can be triggered by metabolic stressors such as illness, high-protein intake, or surgery. The evidence strength for this specific variant is currently categorized as limited, meaning that while it is recognized as a pathogenic variant in clinical databases, the full range of its clinical impact and the predictability of symptoms remain subjects of ongoing study. It is important to note that the presence of a variant does not always guarantee a specific clinical outcome, as other genetic and environmental factors often influence how a condition manifests in an individual.
Population Frequency
The rs68170503 variant is considered rare, with a reported allele frequency in the gnomAD database of less than 0.0001. Due to its rarity and X-linked inheritance, it is not commonly found in the general population.
Navigating Genetic Information
If you have received information regarding the rs68170503 variant, it is essential to approach this data with the guidance of a qualified healthcare professional, such as a genetic counselor or a metabolic specialist. Genetic testing results can be complex, and the presence of a variant does not constitute a medical diagnosis. A clinician can help interpret what this finding means in the context of your personal and family health history, as well as your current symptoms. You should never make changes to your diet, lifestyle, or medical management based solely on a genetic report without consulting your doctor. If you are concerned about potential symptoms of hyperammonemia, such as unexplained confusion, lethargy, or vomiting, seek medical attention promptly. Your healthcare provider is the best resource for determining if further diagnostic testing or clinical monitoring is appropriate for your specific situation.
How common is this variant?
The rs68170503 variant is rare, with a gnomAD allele frequency of less than 0.0001.
Frequently asked questions
What is ornithine transcarbamylase deficiency?
It is an X-linked genetic disorder that prevents the body from properly breaking down ammonia, leading to its accumulation in the blood. This can cause serious neurological issues if not managed.
Can I be a carrier of this variant?
Yes, because the OTC gene is on the X chromosome, females can be carriers. Carriers may be asymptomatic or experience mild symptoms depending on how their cells express the gene.
Does having this variant mean I have a disease?
Not necessarily. Genetic variants indicate a predisposition, but clinical diagnosis requires a physical examination, blood tests for ammonia levels, and consultation with a specialist.
What should I do if I have this variant?
You should discuss the result with a genetic counselor or a metabolic specialist. They can help you understand the clinical significance and determine if any monitoring is necessary.
Sources & further reading
Educational information only, last refreshed 10/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs68170503?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29